Aktis Oncology, Inc.
Clinical trials sponsored by Aktis Oncology, Inc., explained in plain language.
-
New radioactive therapy targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-phase study tests a new radioactive drug (B7-H3 radiopharmaceutical) in people with advanced prostate cancer that no longer responds to hormone therapy. The goal is to see if it is safe and can shrink tumors. About 138 adults will take part, including some who have alr…
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New radiation drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug that delivers radiation directly to cancer cells by targeting a protein called Nectin-4. It is for people with advanced solid tumors (like bladder, breast, lung, or cervical cancer) that have not responded to prior treatments. The main goal…
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC